Reuters logo
BRIEF-U.S. appeals court rules for Novartis, Actavis, Apotex and against Allergan, Duke over patents related to eyelash growth
June 10, 2014 / 3:26 PM / in 3 years

BRIEF-U.S. appeals court rules for Novartis, Actavis, Apotex and against Allergan, Duke over patents related to eyelash growth

June 10 (Reuters) - Novartis AG : * Actavis PLC apotex inc win reversal of lower court ruling regarding

two patents related to Allergan inc’s latisse -- court ruling * U.S federal circuit court of appeals reverses lower court finding with

respect to validity of patents for latisse, a topical solution to stimulate

eyelash growth * Federal circuit says patents at issue belong to Allergan, Duke university * Federal circuit says vacates injunction barring sale of competing products

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below